Albireo Pharma EPS - Earnings per Share 2010-2022 | ALBO
Albireo Pharma eps - earnings per share from 2010 to 2022. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Albireo Pharma Annual EPS |
| 2021 |
$-1.77 |
| 2020 |
$-6.73 |
| 2019 |
$-5.04 |
| 2018 |
$-3.94 |
| 2017 |
$-3.12 |
| 2016 |
$-13.19 |
| 2016 |
$-6.45 |
| 2015 |
$-13.70 |
| 2014 |
$-19.82 |
| 2013 |
$-37.24 |
| 2012 |
$-57.36 |
| 2011 |
$-40.84 |
| 2010 |
$-190.39 |
| 2009 |
$-218.62 |
| Albireo Pharma Quarterly EPS |
| 2022-09-30 |
$-1.92 |
| 2022-06-30 |
$-2.04 |
| 2022-03-31 |
$-2.19 |
| 2021-12-31 |
$-0.48 |
| 2021-09-30 |
$2.90 |
| 2021-06-30 |
$-1.90 |
| 2021-03-31 |
$-2.29 |
| 2020-12-31 |
$-1.16 |
| 2020-09-30 |
$-1.96 |
| 2020-06-30 |
$-1.38 |
| 2020-03-31 |
$-2.23 |
| 2019-12-31 |
$-0.57 |
| 2019-09-30 |
$-1.73 |
| 2019-06-30 |
$-1.35 |
| 2019-03-31 |
$-1.39 |
| 2018-12-31 |
$-1.40 |
| 2018-09-30 |
$-1.17 |
| 2018-06-30 |
$-1.22 |
| 2018-03-31 |
$-0.15 |
| 2017-12-31 |
$-0.47 |
| 2017-09-30 |
$-0.73 |
| 2017-06-30 |
$-0.86 |
| 2017-03-31 |
$-1.06 |
| 2016-12-31 |
$11.64 |
| 2016-09-30 |
$-13.32 |
| 2016-06-30 |
$0.69 |
| 2016-03-31 |
$-12.20 |
| 2015-12-31 |
$-1.50 |
| 2015-09-30 |
$0.00 |
| 2015-06-30 |
$-3.60 |
| 2015-03-31 |
$-5.41 |
| 2014-12-31 |
$-6.01 |
| 2014-09-30 |
$0.00 |
| 2014-06-30 |
$-4.51 |
| 2014-03-31 |
$-8.71 |
| 2013-12-31 |
$-3.60 |
| 2013-09-30 |
$0.00 |
| 2013-06-30 |
$-19.82 |
| 2013-03-31 |
$-11.11 |
| 2012-12-31 |
$-7.81 |
| 2012-09-30 |
$0.00 |
| 2012-06-30 |
$-15.62 |
| 2012-03-31 |
$-13.51 |
| 2011-12-31 |
$-14.11 |
| 2011-09-30 |
$0.00 |
| 2011-06-30 |
$-14.41 |
| 2011-03-31 |
$-25.23 |
| 2010-12-31 |
$-24.02 |
| 2010-09-30 |
$0.00 |
| 2010-06-30 |
$-43.24 |
| 2010-03-31 |
$-52.85 |
| 2009-12-31 |
$-56.46 |
| 2009-09-30 |
$0.00 |
| 2009-06-30 |
$-56.46 |
| 2009-03-31 |
$-58.86 |
